Joseph B. Laudano

Statistics

Publications

Citations

155

H-Index

Active since

2011

Affiliations

Nema Research (United States)(Current)

Joseph B. Laudano is an author at Nema Research (United States) specializing in clinical pharmacology, antimicrobial pharmacotherapy, and ceftriaxone therapy.

Publications per year

2011–2012

Publications

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

H. David Friedland, Tanya O’Neal, Donald Biek et al. · Antimicrobial Agents and Chemotherapy · 2012 · 69 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia

Douglas R. Rank, H. David Friedland, Joseph B. Laudano · Journal of Antimicrobial Chemotherapy · 2011 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Day 4 Clinical Response of Ceftaroline Fosamil Versus Ceftriaxone for Community-Acquired Bacterial Pneumonia

Paul B. Eckburg, H. David Friedland, Lily Llorens et al. · Infectious Diseases in Clinical Practice · 2012 · 23 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration

Brahma N. Singh, Mahendra G. Dedhiya, James C. DiNunzio et al. · American Journal of Health-System Pharmacy · 2011 · 10 citations

Pharmacy, Pharmaceutics, Pharmacology +13

1–4 of 4